Cryptococcus neoformans Fatal Sepsis in a Chronic Lymphocytic Leukemia Patient Treated with Alemtuzumab: Case Report and Review of the Literature

被引:13
作者
Bassetti, M. [1 ]
Repetto, E. [1 ]
Mikulska, M. [1 ]
Miglino, M. [2 ]
Clavio, M. [2 ]
Gobbi, M. [2 ]
Righi, E. [1 ]
Viscoli, C. [1 ]
机构
[1] San Martino Hosp, Div Infect Dis, Genoa, Italy
[2] San Martino Hosp, Dept Hematol, Genoa, Italy
关键词
Chronic lymphocytic leukemia; alemtuzumab; cryptococcosis; liposomal amphothericin B; RECIPIENTS RECEIVING ALEMTUZUMAB; INFECTIOUS COMPLICATIONS; LYMPHOPROLIFERATIVE DISORDERS; RENAL-TRANSPLANTATION; PROGNOSTIC FACTORS; FUNGAL-INFECTIONS; INDUCTION; MALIGNANCIES; PROPHYLAXIS; MENINGITIS;
D O I
10.1179/joc.2009.21.2.211
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cryptococcosis is a disseminated fungal disease typically associated with immunosuppression and characterized by high mortality rates. Cryptococcus neoformans has been reported to be isolated from blood cultures in around 20% of patients with cryptococcosis, and cryptococcemia has been correlated with poor prognosis. We report a case of fatal C. neoformans fungemia in a neutropenic patient with a history of chronic lymphocytic leukemia treated with alemtuzumab. The patient presented with loss of consciousness and died after 5 days of antifungal therapy with liposomal amphotericin B. The international literature regarding opportunistic infections after immunosuppressive therapy with alemtuzumab with particular attention on fungal infections has also been reviewed.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 21 条
[1]   Cryptococcosis [J].
Chayakulkeeree, Methee ;
Perfect, John R. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2006, 20 (03) :507-+
[2]   PROGNOSTIC FACTORS IN CRYPTOCOCCAL MENINGITIS - STUDY IN 111 CASES [J].
DIAMOND, RD ;
BENNETT, JE .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :176-181
[3]  
Gorkom BAPLV, 2007, NETH J MED, V65, P333
[4]   Cryptococcaemia: clinical features and prognostic factors [J].
Jean, SS ;
Fang, CT ;
Shau, WY ;
Chen, YC ;
Chang, SC ;
Hsueh, PR ;
Hung, CC ;
Luh, KT .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2002, 95 (08) :511-518
[5]   Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies [J].
Maertens, Johan .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (04) :275-282
[6]   Campath-1H induction and the incidence of infectious complications in adult renal transplantation [J].
Malek, SK ;
Obmann, MA ;
Gotoff, RA ;
Foltzer, MA ;
Hartle, JE ;
Potdar, S .
TRANSPLANTATION, 2006, 81 (01) :17-20
[7]  
Martin SI, 2006, CLIN INFECT DIS, V43, P16, DOI 10.1086/504811
[8]  
MOLICA S, 1993, HAEMATOLOGICA, V78, P374
[9]   Fungal infections in transplant recipients receiving alemtuzumab [J].
Nath, DS ;
Kandaswamy, R ;
Gruessner, R ;
Sutherland, DER ;
Dunn, DL ;
Humar, A .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :934-936
[10]   Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab [J].
Nosari, A. ;
Tedeschi, A. ;
Ricci, F. ;
Montillo, M. .
HAEMATOLOGICA, 2008, 93 (02) :E30-E31